Bryson N

Reunion Neuroscience, Inc, Morristown, NJ.

3 papers · ORCID

ArticlePsilocybin

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.

Ludbrook G, Bryson N, Taylor B +6

Europe PMC2025
ArticleKetamine

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Yermus R, Bottos J, Bryson N +18

Europe PMC2024
ArticlePsilocybin

RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-<i>N</i>,<i>N</i>-diisopropyltryptamine.

Bryson N, Alexander R, Asnis-Alibozek A +1

Europe PMC2024